HIGH EFFICACY OF THE CURRENTLY RECOMMENDED REGIMENS OF 2 DIRECT ACTING ANTIVIRALS (DAAS)+RIBAVIRIN (R) IN HCV GENOTYPE 4 (GT4) PATIENTS (PTS) WITH ADVANCED FIBROSIS OR CIRRHOSIS IN HERACLIS REAL-WORLD COHORT

Ioannis Goulis  1     Ioannis Elefsiniotis  2     Stylianos Karatapanis  3     John Koskinas  4     Panagiota Ioannidou  4     Spilios Manolakopoulos  5     John Vlachogiannakos     Martha Oikonomopoulou     DIMITRIOS SAMONAKIS     Emanuel Manesis     Melanie Deutsch     Andreas Kapatais     George Dalekos     Emanuel Sinakos     Maria Schina     Vassilios Sevastianos     Ioannis Ketikogl    
1 Aristotle University of Thessaloniki,Thessaloniki,Greece
2 National and Kapodistrian University of Athens,Athens,Greece
3 General Rodos Hospital,Rodos Island,Greece
4 National & Kapodistrian University of Athens Medical School,Athens,Greece
5 Ippokratio,Agi

Conference
UEG Week 2018

Citation
United European Gastroenterology Journal 2018; 6 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing